Cargando…

Comparison of Intraperitoneal Bupivacaine and Intravenous Ketorolac for Postoperative Pain Management Following Laparoscopic Cholecystectomy

BACKGROUND: Postoperative pain following laparoscopic cholecystectomy (LC) arises from incision sites and residual intraperitoneal CO(2) gas. Opioids as a class of pain-relieving drugs are broadly used to control pain after LC; however, these drugs can cause various side effects. OBJECTIVES: The pur...

Descripción completa

Detalles Bibliográficos
Autores principales: Arabzadeh, AmirAhmad, Seyedsadeghi, Mirsalim, Sadeghi, Nahideh, Nejati, Kazem, Mohammadian Erdi, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Briefland 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909541/
https://www.ncbi.nlm.nih.gov/pubmed/35291402
http://dx.doi.org/10.5812/aapm.114623
_version_ 1784666197921366016
author Arabzadeh, AmirAhmad
Seyedsadeghi, Mirsalim
Sadeghi, Nahideh
Nejati, Kazem
Mohammadian Erdi, Ali
author_facet Arabzadeh, AmirAhmad
Seyedsadeghi, Mirsalim
Sadeghi, Nahideh
Nejati, Kazem
Mohammadian Erdi, Ali
author_sort Arabzadeh, AmirAhmad
collection PubMed
description BACKGROUND: Postoperative pain following laparoscopic cholecystectomy (LC) arises from incision sites and residual intraperitoneal CO(2) gas. Opioids as a class of pain-relieving drugs are broadly used to control pain after LC; however, these drugs can cause various side effects. OBJECTIVES: The purpose of this study was to compare the efficacy of intraperitoneal injection of bupivacaine with that of intravenous ketorolac in managing postoperative pain in patients who had undergone LC. METHODS: This randomized, double-blind clinical trial was carried out on patients who had undergone LC. Ninety patients who had undergone elective LC were randomly divided into 3 groups (n = 30 for each group). Group A received 40 mL of 0.25% bupivacaine solution intraperitoneally at the end of the operation; group B received 30 mg of ketorolac intravenously 30 minutes before surgery and every 8 hours after surgery, and patients in group C received normal saline intraperitoneally and intravenous injection. The patients were postoperatively assessed for Visual Analog Scale (VAS) scores, postoperative opioid consumption, shoulder pain, side effects (sedation, nausea, and vomiting), and satisfaction. The data were analyzed using SPSS. P values < 0.05 were considered significant. RESULTS: The intraperitoneal injection of bupivacaine and intravenous injection of ketorolac were significantly effective in reducing postoperative abdominal pain, shoulder pain, and incidence of nausea and vomiting compared to the placebo group (P < 0.001). Although intraperitoneal bupivacaine and intravenous ketorolac had no significant difference in pain relief compared with each other, patients in both bupivacaine and ketorolac groups were significantly more satisfied with their analgesia compared to the control group (P < 0.001). CONCLUSIONS: Intraperitoneal injection of bupivacaine and intravenous injection of ketorolac both are safe and effective methods to control pain, nausea, and vomiting after LC.
format Online
Article
Text
id pubmed-8909541
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Briefland
record_format MEDLINE/PubMed
spelling pubmed-89095412022-03-14 Comparison of Intraperitoneal Bupivacaine and Intravenous Ketorolac for Postoperative Pain Management Following Laparoscopic Cholecystectomy Arabzadeh, AmirAhmad Seyedsadeghi, Mirsalim Sadeghi, Nahideh Nejati, Kazem Mohammadian Erdi, Ali Anesth Pain Med Research Article BACKGROUND: Postoperative pain following laparoscopic cholecystectomy (LC) arises from incision sites and residual intraperitoneal CO(2) gas. Opioids as a class of pain-relieving drugs are broadly used to control pain after LC; however, these drugs can cause various side effects. OBJECTIVES: The purpose of this study was to compare the efficacy of intraperitoneal injection of bupivacaine with that of intravenous ketorolac in managing postoperative pain in patients who had undergone LC. METHODS: This randomized, double-blind clinical trial was carried out on patients who had undergone LC. Ninety patients who had undergone elective LC were randomly divided into 3 groups (n = 30 for each group). Group A received 40 mL of 0.25% bupivacaine solution intraperitoneally at the end of the operation; group B received 30 mg of ketorolac intravenously 30 minutes before surgery and every 8 hours after surgery, and patients in group C received normal saline intraperitoneally and intravenous injection. The patients were postoperatively assessed for Visual Analog Scale (VAS) scores, postoperative opioid consumption, shoulder pain, side effects (sedation, nausea, and vomiting), and satisfaction. The data were analyzed using SPSS. P values < 0.05 were considered significant. RESULTS: The intraperitoneal injection of bupivacaine and intravenous injection of ketorolac were significantly effective in reducing postoperative abdominal pain, shoulder pain, and incidence of nausea and vomiting compared to the placebo group (P < 0.001). Although intraperitoneal bupivacaine and intravenous ketorolac had no significant difference in pain relief compared with each other, patients in both bupivacaine and ketorolac groups were significantly more satisfied with their analgesia compared to the control group (P < 0.001). CONCLUSIONS: Intraperitoneal injection of bupivacaine and intravenous injection of ketorolac both are safe and effective methods to control pain, nausea, and vomiting after LC. Briefland 2021-12-27 /pmc/articles/PMC8909541/ /pubmed/35291402 http://dx.doi.org/10.5812/aapm.114623 Text en Copyright © 2021, Author(s) https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
spellingShingle Research Article
Arabzadeh, AmirAhmad
Seyedsadeghi, Mirsalim
Sadeghi, Nahideh
Nejati, Kazem
Mohammadian Erdi, Ali
Comparison of Intraperitoneal Bupivacaine and Intravenous Ketorolac for Postoperative Pain Management Following Laparoscopic Cholecystectomy
title Comparison of Intraperitoneal Bupivacaine and Intravenous Ketorolac for Postoperative Pain Management Following Laparoscopic Cholecystectomy
title_full Comparison of Intraperitoneal Bupivacaine and Intravenous Ketorolac for Postoperative Pain Management Following Laparoscopic Cholecystectomy
title_fullStr Comparison of Intraperitoneal Bupivacaine and Intravenous Ketorolac for Postoperative Pain Management Following Laparoscopic Cholecystectomy
title_full_unstemmed Comparison of Intraperitoneal Bupivacaine and Intravenous Ketorolac for Postoperative Pain Management Following Laparoscopic Cholecystectomy
title_short Comparison of Intraperitoneal Bupivacaine and Intravenous Ketorolac for Postoperative Pain Management Following Laparoscopic Cholecystectomy
title_sort comparison of intraperitoneal bupivacaine and intravenous ketorolac for postoperative pain management following laparoscopic cholecystectomy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909541/
https://www.ncbi.nlm.nih.gov/pubmed/35291402
http://dx.doi.org/10.5812/aapm.114623
work_keys_str_mv AT arabzadehamirahmad comparisonofintraperitonealbupivacaineandintravenousketorolacforpostoperativepainmanagementfollowinglaparoscopiccholecystectomy
AT seyedsadeghimirsalim comparisonofintraperitonealbupivacaineandintravenousketorolacforpostoperativepainmanagementfollowinglaparoscopiccholecystectomy
AT sadeghinahideh comparisonofintraperitonealbupivacaineandintravenousketorolacforpostoperativepainmanagementfollowinglaparoscopiccholecystectomy
AT nejatikazem comparisonofintraperitonealbupivacaineandintravenousketorolacforpostoperativepainmanagementfollowinglaparoscopiccholecystectomy
AT mohammadianerdiali comparisonofintraperitonealbupivacaineandintravenousketorolacforpostoperativepainmanagementfollowinglaparoscopiccholecystectomy